QUALITY OF LIFE AND PSYCHO-EMOTIONAL STATUS IN PATIENTS WITH PSORIATIC ARTHRITIS
Keywords:
Key words: psoriatic arthritis, basic therapy, quality of life, psychoemotional status.Abstract
The dynamics of quality of life (QOL) and psychoemotional status in patients
with psoriatic arthritis (PA) under the influence of basic therapy with methotrexate
(n=28) and sulfasalazine (n=20) were studied. The control group consisted of 25
patients receiving only nonsteroidal anti-inflammatory drugs. Therapy with basic drugs
in patients with PA leads to a rapid and long-lasting clinical effect, improves the quality
of life of patients according to the SF-36 questionnaire. The positive effect of basic
therapy on depression symptoms is not always pronounced and is significant only in
the methotrexate group.
References
LITERATURE
1. Хамраева, Н. А., Султонов, И. И., & Хасанов, Ф. Ш. У. (2019). Кожные
проявления у больных системной красной волчанкой. Вопросы науки и
образования, (28 (77)), 128-131.
2. Sultonov, I. I., Kh, Z. S., Ruzybakieva, M. R., Kireev, V. V., Aripova, T. U., &
Suyarov, A. A. (2021). Pharmacogenetic Aspects of Drug Resistance in
Rheumatoid Arthritis. Annals of the Romanian Society for Cell Biology, 4147-4150.
3. Тоиров, А. Э., Султонов, И. И., & Тоиров, Э. С. (2020). ЗНАЧЕНИЕ
ДИСФУНКЦИИ ПОЧЕК У БОЛЬНЫХ ОСТРЫМ ИНФАРКТОМ
МИОКАРДА НА ФОНЕ САХАРНОГО ДИАБЕТА 2-ГО ТИПА. Вестник
науки и образования, (9-3 (87)), 86-91.
4. Kireev, V. V., & Sultonov, I. I. (2021). Genetic Engineered Preparations-An
Innovative Approach in the Treatment of Rheumatoid Arthritis. Annals of the
Romanian Society for Cell Biology, 4114-4119.
5. Hamraeva, N. A., Sultonov, I. I., & Hasanov, F. S. (2020). Systemic lupus
erythematosus treatment strategy. Journal of Critical Reviews, 7(9), 269-270.
6. Иргашева, У. З., Султонов, И. И., & Тоиров, Д. Р. (2013). Признаки дебюта
системной красной волчанки. Академический журнал Западной Сибири, 9(1),
15-15.
7. Xasanov, F. S., & Sultonov, I. I. (2023). RHEUMATOID ARTHRITIS TREATED
WITH DMARDS AND CARDIOVASCULAR DISEASE RISK. Oriental Journal
of Medicine and Pharmacology, 3(02), 45-52.
8. Sultonov, I. I., Xasanov, F. S., Eshmuratov, S., Uralov, R. S., Shukurova, D., &
Ziyadullayev, S. X. Predictors of Systemic Lupus Erythematosus: A Case-control
Study. International journal of health sciences, 6(S10), 175-182.
9. Ibragimov, K., Sultonov, I., & Ravshanova, M. (2024). The Effectiveness of the
Combination Therapy with biologic DMARDS in Rheumatoid Arthritis. Frontiers
of Global Science, 2(1), 17-24.
10. Ziyadullaev, S. K., Sultonov, I. I., Dushanova, G. A., & Akbarovna, K. S. (2021).
The Effectiveness Of Pharmacotherapy For Dmards With Ra Depending On The
C3435t Polymorphism Of The Mdr1 Gene. Int. J. of Aquatic Science, 12(3), 2908-
2916.
11. Sobirov, A., & Sultonov, I. (2024). COMPREHENSIVE ANALYSIS OF
CLINICAL NEUROPSYCHOLOGICAL AND NEUROIMAGING ASPECTS OF
ALZHEIMER'S DISEASE. Frontiers of Global Science, 2(1).
12. Islomovich, S. I., Alisherovna, K. M., & Djamshedovna, K. D. (2024). FACTORS
OF OSTEOPOROSIS IN PATIENTS WITH CORONARY HEART DISEASE IN
COMBINATION WITH RHEUMATOID ARTHRITIS. Ta'lim innovatsiyasi va
integratsiyasi, 31(2), 132-138.
13. Islomovich, S. I. (2024). GENDER CHARACTERISTICS OF THE CURRENT
RHEUMATOID ARTHRITIS. International journal of medical sciences, 4(10), 3-
8.
14. Islomovich, S. I. (2024). FEATURES OF THE COURSE OF PREGNANCY IN
RHEUMATOID ARTHRITIS. International journal of medical sciences, 4(10),
77-84.
15. Djamshedovna, K. D., Alisherovna, K. M., & Islomovich, S. I. (2024). ARTERIAL
HYPERTENSION IN RHEUMATOID ARTHRITIS. Ta'lim innovatsiyasi va
integratsiyasi, 31(2), 139-145.
16. Alisherovna, K. M., Nizamitdinovich, K. S., & Islomovich, S. I. (2024). THERAPY
OF RHEUMATOID ARTHRITIS DURING PREGNANCYTHE. Ta'lim
innovatsiyasi va integratsiyasi, 31(2), 172-180.
17. Nizamitdinovich, K. S., Alisherovna, K. M., & Islomovich, S. I. (2024). CLINICAL
COURSE OF BRONCHIAL ASTHMA IN PATIENTS WITH THYROID
DISEASES. Ta'lim innovatsiyasi va integratsiyasi, 31(2), 181-187.
18. Alisherovna, K. M., Islomovich, S. I., & Djamshedovna, K. D. (2024).
PSYCHOEMOTIONAL STATE AND QUALITY OF LIFE IN PATIENTS WITH
SYSTEMIC LUPUS ERYTHEMATOSUS. Ta'lim innovatsiyasi va
integratsiyasi, 31(2), 124-131.
19. Alisherovna, K. M., Nizamitdinovich, K. S., & Islomovich, S. I. (2024).
FEATURES OF BONE MINERAL DENSITY IN PATIENTS WITH DISEASES
OF THE DIGESTIVE SYSTEM. Ta'lim innovatsiyasi va integratsiyasi, 31(2),
162-171.
20. Ilkhom, S. (2023). CAJAM–VOLUME 1. ISSUE 1. 2023. Central Asian Journal
of Advanced Medicine, 1(01), 16-19.
21. Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). REVMATOID ARTRIT
KASALLIGIDA METABOLIK REGULYASIYA. Научный Фокус, 2(19), 429-
434.
22. Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). REVMATOID ARTRITDA
STEROID DIABET OLDINI OLISH. Научный Фокус, 2(19), 425-428.
23. Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). REVMATOID ARTRIT
KASALLIGIDA METORTRIT VA NOSTEROIDLARNI BIRGA QOLLASHDA
TERAPEVTIK SAMARADORLIK. Научный Фокус, 2(19), 418-424.
24. Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). TIZIMLI QIZIL YUGURIK
KASALLIGI. Научный Фокус, 2(19), 413-417.
25. Sherbekovich, U. R., & Eldorovich, E. S. (2024). PROFILE OF
AUTOANTIBODIES IN SYSTEMIC SCLERODERMA. International journal of
medical sciences, 4(05), 257-265.
26. Eldorovich, E. S., & Sherbekovich, U. R. (2024). THE CLINICAL
SIGNIFICANCE OF INTERLEUKIN-4 IN SYSTEMIC
SCLERODERMA. Spectrum Journal of Innovation, Reforms and
Development, 27, 51-58.
27. Sherbekovich, U. R., & Eldorovich, E. S. (2024). SEVERITY INDEX IN
PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Spectrum Journal
of Innovation, Reforms and Development, 27, 75-82.
28. Eldorovich, E. S., & Sherbekovich, U. R. (2024). DYNAMIC CHANGES IN THE
ACTIVITY INDEX AND THE TOTAL SEVERITY INDEX IN PATIENTS
WITH SYSTEMIC SCLERODERMA AND INTERSTITIAL LUNG DISEASE
OVER A 5-YEAR FOLLOW-UP PERIOD. International journal of medical
sciences, 4(05), 281-289.
29. Sherbekovich, U. R. (2024). FEATURES OF ANKYLOSING SPONDYLITIS IN
MEN AND WOMEN. International journal of medical sciences, 4(11), 156-162.
30. Khusainova, M. A., Eshmamatova, F. B., Ismoilova, K. T., & Mamadiyorova, M.
M. (2023). METABOLIC SYNDROME IN RHEUMATOID ARTHRITIS AS A CRITERION OF CARDIOVASCULAR RISK. Oriental renaissance: Innovative,
educational, natural and social sciences, 3(1), 331-339.
31. Khusainova, M. A., Vakhidov, J. J., Khayitov, S. M., & Mamadiyorova, M. M.
(2023). Cardiac arrhythmias in patients with rheumatoid arthritis. Science and
Education, 4(2), 130-137.
32. Khusainova, M. A., Ergashova, M. M., Eshmamatova, F. B., & Khayitov, S. M.
(2023). Features of quality of life indicators in patients with pneumonia. Science
and Education, 4(2), 138-144.
33. Alisherovna, K. M., Erkinovna, S. D., Duskobilovich, B. S., & Samandarovich, T.
H. (2024). ARTERIAL HYPERTENSION IN THYROTOXICOSIS AND
REMODELING OF THE LEFT VENTRICLE OF THE HEART. Ta'lim
innovatsiyasi va integratsiyasi, 19(4), 114-121.
34. Alisherovna, K. M., Erkinovna, S. D., Yazdonkulovna, X. M., & Zafarovna, C. M.
M. (2024). ATRIAL FIBRILLATION IN THYROTOXICOSIS–
DETERMINANTS OF DEVELOPMENT AND CONSERVATION. Ta'lim
innovatsiyasi va integratsiyasi, 19(4), 103-113.
35. Alisherovna, K. M., Mansurovna, M. D., Erkinovna, N. D., Farxodovna, X. R.,
Toxirovna, M. M., Tolibovna, R. D., & Yorkinovna, E. N. (2024). ARTERIAL
HYPERTENSION AND THYROID STATUS IN PATIENTS OF DIFFERENT
AGES. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 122-129.
36. Alisherovna, K. M., Ismatullayevich, M. A., & Nuriddinovna, E. N. (2024).
FEATURES OF HEART FAILURE IN PATIENTS WITH CORONARY HEART
DISEASE AND THYROTOXICOSIS. Ta'lim innovatsiyasi va
integratsiyasi, 19(4), 52-61.
37. Alisherovna, K. M., Boymamatovna, E. F., Tursunboyevna, I. K., & Mashrabovna,
M. M. METABOLIC SYNDROME IN RHEUMATOID ARTHRITIS AS A
CRITERION OF CARDIOVASCULAR RISK.
38. Alisherovna, K. M., Habibulloyevna, I. M., & Voxidovna, R. F. (2024).
STRUCTURAL AND FUNCTIONAL FEATURES OF THE LEFT VENTRICLE
IN PATIENTS WITH HEART FAILUREIN ISCHEMIC HEART DISEASE AND
THYROTOXICOSIS. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 71-81.
